Form 4 Filing for Bristol Myers Squibb Co. - Insider Transaction

This filing reports a transaction by Theodore R. Samuels II, a director at Bristol Myers Squibb Co. (BMY), on June 30, 2026. Samuels acquired 889.448 Deferred Share Units at a price of $57.62 per unit. These units are convertible into shares of common stock upon settlement, typically when the reporting person ceases to be a director or at a future specified date. The acquisition increases his total holdings to 70,360.664 units, which includes deferred compensation and reinvested dividends. The filing is designated as Form 4, indicating a change in beneficial ownership by an insider.